“The event was the Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference, held over two days in Islamabad on July 17–18, 2026. Business leaders, officials, and health experts from both countries attended. On the final day, Federal Health Minister Syed Mustafa Kamal briefed the media on the results. He said 16 contracts and 80 memoranda of understanding (MoUs) had been finalised. Of the total, contracts worth $600 million were signed, along with MoUs worth another $250 million, for a total of $850 million in agreements. Mustafa Kamal called it a key economic milestone, marking a new stage in healthcare cooperation between the two countries.”
“Of all the deals signed, 18 were tied to herbal medicines, a notable share of the total. Herbal medicine has long been an important field in China, and Pakistan now appears to be growing its own interest in this area. These agreements could help build stronger supply chains and research links in natural and traditional health products. Pakistan already has a sizeable pharmaceutical manufacturing base of its own, with hundreds of local companies producing finished medicines for the domestic market. The gap has always been further upstream, in the raw chemical ingredients, known as active pharmaceutical ingredients, that go into those finished products. Most of that supply currently comes from abroad, which is exactly the gap these new deals are meant to help close.”
https://thedailycpec.com/china-backs-850m-boost-for-pakistans-pharma-sector/